perindoprilat

A non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Perindoprilat inhibits ACE and, thus, the conversion… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND Angiotensin-converting enzyme inhibitors (ACE-I) protect against the development of glomerulosclerosis using… (More)
Is this relevant?
2004
2004
Not all of the cardiovascular effects of angiotensin-converting enzyme (ACE) inhibitors can be attributed to changes in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Angiotensin-I converting enzyme (ACE) inhibitor is used widely as an antihypertensive agent, and it has been suggested recently… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • table 1
Is this relevant?
1999
1999
The renal effects of acute hypoxemia and the ability of perindoprilat, a potent angiotensin-converting enzyme inhibitor, to… (More)
Is this relevant?
1999
1999
Long-term angiotensin-converting enzyme (ACE) inhibition may reduce ischemic events in patients with coronary artery disease, but… (More)
Is this relevant?
1997
1997
To examine whether the bradykinin-nitric oxide (NO) pathway directly participates in the antihypertrophic property of angiotensin… (More)
Is this relevant?
1996
1996
BACKGROUND Cold pressor test (CPT)-induced and flow-dependent epicardial coronary artery dilations are impaired in patients with… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The present study was designed to determine whether bradykinin induces endothelium-dependent hyperpolarization of vascular smooth… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1992
1991
1991
Experiments were designed to study the effects of perindoprilat (S 9780) on endothelium-dependent and -independent relaxations… (More)
Is this relevant?